The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: Implication for drug abuse

Life Sciences

Volumn 77, Issue 14, 2005, Pages 1612-1624

  Hayashi, Teruo ^a   Su, Tsung Ping ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

(+)Pentazocine; Cholesterol; Cocaine; Cytoskeleton; Ganglioside; Lipid; Methamphetamine; Microdomain; Neuritogenesis; NG108; PC12; Raft; Sigma; Sigma ligand; Sigma receptor; Trophic factor

Indexed keywords

BRAIN PROTEIN; CHOLESTEROL; COCAINE; DETERGENT; LIPID; MEMBRANE LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PSYCHOSTIMULANT AGENT; SIGMA 1 OPIATE RECEPTOR; STEROL;

BEHAVIOR; BIOLOGICAL ACTIVITY; BRAIN; CELL DIFFERENTIATION; CELL MEMBRANE; CONFERENCE PAPER; DRUG ABUSE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EXPERIMENTAL MODEL; HUMAN; LIPID RAFT; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; MEMBRANE RECONSTITUTION; MOLECULAR BIOLOGY; MORPHOLOGY; NERVE FUNCTION; NEURITE; NEUROBIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; OLIGODENDROGLIA; PRECURSOR; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SENSITIZATION; STIMULATION;

BIOLOGICAL TRANSPORT; BRAIN; CELL DIFFERENTIATION; ENDOPLASMIC RETICULUM; HUMANS; LIPID METABOLISM; MEMBRANE MICRODOMAINS; RECEPTORS, SIGMA; SUBSTANCE-RELATED DISORDERS;

EID: 23044482434     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.009     Document Type: Conference Paper

References (74)

1. G. Alonso, V. Phan, I. Guillemain, M. Saunier, A. Legrand, M. Anoal, and T. Maurice Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system Neuroscience 97 1 2000 155 170
2. R.G. Anderson Caveolae: where incoming and outgoing messengers meet Proceedings of the National Academy of Sciences of the USA 90 23 1993 10909 10913
3. E. Aydar, C.P. Palmer, V.A. Klyachko, and M.B. Jackson The sigma receptor as a ligand-regulated auxiliary potassium channel subunit Neuron 34 3 2002 399 410
4. B.A. Barres, and M.C. Raff Axonal control of oligodendrocyte development Journal of Cell Biology 47 6 1999 1123 1128
5. N.G. Bazan Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor Journal of Lipid Research 44 12 2003 2221 2233
6. J.M. Bourre Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing Journal of Nutrition, Health & Aging 8 3 2004 163 174
7. W.D. Bowen, S.B. Hellewell, and K.A. McGarry Evidence for a multi-site model of the rat brain sigma receptor European Journal of Pharmacology 163 2-3 1989 309 318
8. N. Braverman, P. Lin, F.F. Moebius, C. Obie, A. Moser, H. Glossmann, W.R. Wilcox, D.L. Rimoin, M. Smith, L. Kratz, R.I. Kelley, and D. Valle Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome Nature Genetics 22 3 1999 291 294
9. J.L. Bruses, N. Chauvet, and U. Rutishauser Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons Journal of Neuroscience 21 2 2001 504 512
10. S. Chalon, S. Vancassel, L. Zimmer, D. Guilloteau, and G. Durand Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission Lipids 36 9 2001 744 937
11. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 1993 921 923
12. S.M. Crain, and K.F. Shen GM1 ganglioside-induced modulation of opioid receptor-mediated functions Annals of the New York Academy of Sciences 845 1998 106 125
13. K.W. Crawford, and W.D. Bowen Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines Cancer Research 62 1 2002 313 322
14. J.M. Dietschy, and S.D. Turley Cholesterol metabolism in the brain Current Opinion in Lipidology 12 2 2001 105 112
15. J.M. Dietschy, and S.D. Turley Cholesterol metabolism in the central nervous system during early development and in the mature animal Journal of Lipid Research 45 8 2004 1375 1397
16. D. Dussossoy, P. Carayon, S. Belugou, D. Feraut, A. Bord, C. Goubet, C. Roque, H. Vidal, T. Combes, G. Loison, and P. Casellas Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level European Journal of Biochemistry 263 2 1999 377 386
17. A. Gorio Ganglioside enhancement of neuronal differentiation, plasticity, and repair CRC Critical Reviews in Clinical Neurobiology 2 3 1986 241 296
18. L. Gustavsson Brain lipid changes after ethanol exposure Upsala Journal of Medical Sciences. Supplement 48 1990 245 266
19. M. Hanner, F.F. Moebius, A. Flandorfer, H.G. Knaus, J. Striessnig, E. Kempner, and H. Glossmann Purification, molecular cloning, and expression of the mammalian sigma1-binding site Proceedings of the National Academy of Sciences of the USA 93 15 1996 8072 8077
20. T. Hayashi, and T.P. Su Regulating ankyrin dynamics: roles of sigma-1 receptors Proceedings of the National Academy of Sciences of the USA 98 2 2001 491 496
21. T. Hayashi, and T.P. Su Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export Journal of Pharmacology and Experimental Therapeutics 306 2 2003 718 725
22. T. Hayashi, and T.P. Su Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells Journal of Pharmacology and Experimental Therapeutics 306 2 2003 726 733
23. T. Hayashi, and T.P. Su Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders CNS Drugs 18 5 2004 269 284
24. T. Hayashi, and T.P. Su Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation Proceedings of the National Academy of Sciences of the USA 101 41 2004 14949 14954
25. Hayashi, T., Su, T.P., in press. Subcellular localization and dynamics of sigma-1 receptors. In: Matsumoto, R., Bowen, W.D., Su, T.P. (Eds.), Sigma Receptors: Chemistry, Cell Biology and Clinical Implications. Kluwer Academic Publishers, Norwell, MA.
26. T. Hayashi, T. Maurice, and T.P. Su Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration Journal of Pharmacology and Experimental Therapeutics 293 3 2000 788 798
27. H. Hering, C.C. Lin, and M. Sheng Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability Journal of Neuroscience 23 8 2003 3262 3271
28. W. Hong, S.J. Nuwayhid, and L.L. Werling Modulation of bradykinin-induced calcium changes in SH-SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism Synapse 54 2 2004 102 110
29. D.F. Horrobin, A.I. Glen, and K. Vaddadi The membrane hypothesis of schizophrenia Schizophrenia Research 3 3 1994 195 207
30. Huang, P., Chong, P.L.-G., Xu, W., Yoon, S.I., Chen, C., Liu-Chen, L.Y., 2004. The mu opioid receptor (MOR) expressed in Chinese hamster ovary (CHO) cells constitutively partitions into lipid rafts/caveolae. Society for Neuroscience Abstract. No. 630.11.
31. B.L. Hungund, and S.P. Mahadik Role of gangliosides in behavioral and biochemical actions of alcohol: cell membrane structure and function Alcoholism, Clinical and Experimental Research 7 2 1993 329 339
32. Y. Itzhak Repeated methamphetamine-treatment alters brain sigma receptors European Journal of Pharmacology 230 2 1993 243 244
33. Y.K. Kim, and A.M. Myint Clinical application of low serum cholesterol as an indicator for suicide risk in major depression Journal of Affective Disorder 81 2 2004 161 166
34. C. Labit-Le Bouteiller, M.F. Jamme, M. David, S. Silve, C. Lanau, C. Dhers, C. Picard, A. Rahier, M. Taton, G. Loison, D. Caput, P. Ferrara, and J. Lupker Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step European Journal of Biochemistry 256 2 1998 342 349
35. W.R. Martin Pharmacology of opioids Pharmacological Reviews 35 4 1983 283 323
36. R.R. Matsumoto, Y. Liu, M. Lerner, E.W. Howard, and D.J. Brackett Sigma receptors: potential medications development target for anti-cocaine agents European Journal of Pharmacology 469 1-3 2003 1 12
37. D.H. Mauch, K. Nagler, S. Schumacher, C. Goritz, E.C. Muller, A. Otto, and F.W. Pfrieger CNS synaptogenesis promoted by glia-derived cholesterol Science 294 5545 2001 1354 1357
38. J. Mei, and G.W. Pasternak Sigma1 receptor modulation of opioid analgesia in the mouse Journal of Pharmacology and Experimental Therapeutics 300 3 2002 1070 1074
39. E.A. Miljan, E.J. Meuillet, B. Mania-Farnell, D. George, H. Yamamoto, H.G. Simon, and E.G. Bremer Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides Journal of Biological Chemistry 277 12 2002 10108 10113
40. R.H. Miller Regulation of oligodendrocyte development in the vertebrate CNS Progress in Neurobiology 67 6 2002 451 467
41. Y. Minabe, K. Matsuno, and C.R. Ashby Jr. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study Synapse 33 2 1999 129 140
42. F.P. Monnet, G. Debonnel, and C. de Montigny In vivo electrophysiological evidence for a selective modulation of N-methyl-d-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands Journal of Pharmacology and Experimental Therapeutics 261 1 1992 123 130
43. D.J. Murphy, and J. Vance Mechanisms of lipid-body formation Trends in Biochemical Sciences 24 3 1999 109 115
44. 3H]dopamine release is dependent upon protein kinase C Journal of Pharmacology and Experimental Therapeutics 304 1 2003 364 369
45. M. Ohashi, N. Mizushima, Y. Kabeya, and T. Yoshimori Localization of mammalian NAD(P)H steroid dehydrogenase-like protein on lipid droplets Journal of Biological Chemistry 278 38 2003 36819 36829
46. G. Palacios, A. Muro, J.M. Vela, E. Molina-Holgado, X. Guitart, S. Ovalle, and D. Zamanillo Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system Brain Research 961 1 2003 92 99
47. G. Palacios, A. Muro, E. Verdu, M. Pumarola, and J.M. Vela Immunohistochemical localization of the sigma-1 receptor in Schwann cells of rat sciatic nerve Brain Research 1007 1-2 2004 65 70
48. M. Peeters, P. Romieu, T. Maurice, T.P. Su, J.M. Maloteaux, and E. Hermans Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine European Journal of Neuroscience 9 8 2004 2212 2220
49. S.E. Pfeiffer, A.E. Warrington, and R. Bansal The oligodendrocyte and its many cellular processes Trends in Cell Biology 3 6 1993 191 197
50. R. Quirion, W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam, and D.P. Taylor A proposal for the classification of sigma binding sites Trends in Pharmacological Sciences 13 3 1992 85 86
51. H. Rahmann, W. Probst, and M. Muhleisen Gangliosides and synaptic transmission Japanese Journal of Experimental Medicine 52 6 1982 275 286
52. K. Roepstorff, P. Thomsen, K. Sandvig, and B. van Deurs Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding Journal of Biological Chemistry 277 21 2002 18954 18960
53. P. Romieu, R. Martin-Fardon, and T. Maurice Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference NeuroReport 11 13 2000 2885 2888
54. P. Romieu, V.L. Phan, R. Martin-Fardon, and T. Maurice Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade Neuropsychopharmacology 26 4 2002 444 455
55. P. Seth, F.H. Leibach, and V. Ganapathy Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor Biochemical and Biophysical Research Communications 8;241 2 1997 535 540
56. J. Sharkey, K.A. Glen, S. Wolfe, and M.J. Kuhar Cocaine binding at sigma receptors European Journal of Pharmacology 149 1-2 1988 171 174
57. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 6633 1997 569 572
58. O. Soriani, F. Le Foll, L. Galas, F. Roman, H. Vaudry, and L. Cazin The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductance in frog melanotrophs American Journal of Physiology 277 1999 E73 E80
59. R. Stefanski, Z. Justinova, T. Hayashi, M. Takebayashi, S.R. Goldberg, and T.P. Su Sigma(1) receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls Psychopharmacology (Berl.) 75 1 2004 68 75
60. 3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain Journal of Pharmacology and Experimental Therapeutics 223 2 1982 284 290
61. T.P. Su, and T. Hayashi Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors Trends in Pharmacological Sciences 22 9 2001 456 458
62. T.P. Su, and T. Hayashi Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction Current Medicinal Chemistry 20 2003 2073 2080
63. T.P. Su, E.D. London, and J.H. Jaffe Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems Science 240 4849 1988 219 221
64. S. Takahashi, T. Miwa, and K. Horikomi Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats Neuroscience Letters 289 1 2000 21 24
65. M. Takebayashi, T. Hayashi, and T.P. Su Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants Journal of Pharmacology and Experimental Therapeutics 303 3 2002 1227 1237
66. M. Takebayashi, T. Hayashi, and T.P. Su Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution Synapse 53 2 2004 90 103
67. S.W. Tam Naloxone-inaccessible sigma receptor in rat central nervous system Proceedings of the National Academy of Sciences of the USA 80 21 1983 6703 6707
68. H. Ujike, S. Kuroda, and S. Otsuki Sigma receptor antagonists block the development of sensitization to cocaine European Journal of Pharmacology 296 2 1996 123 128
69. M.T. Vanier Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature Neurochemistry Research 24 4 1999 481 489
70. J.M. Walker, W.D. Bowen, F.O. Walker, R.R. Matsumoto, B. De Costa, and K.C. Rice Sigma receptors: biology and function Pharmacological Reviews 42 4 1990 355 402
71. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 5568 2002 678 682
72. M. Yamabhai, and R.G. Anderson Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts Journal of Biological Chemistry 277 28 2002 24843 24846
73. S. Yehuda, S. Rabinovitz, and D.I. Mostofsky Essential fatty acids are mediators of brain biochemistry and cognitive functions Journal of Neuroscience Research 56 6 1999 565 570
74. H. Zhang, and J. Cuevas Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons Journal of Neurophysiology 87 6 2002 2867 2879